Clinical Trial Results

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

PHASE2 Berkeley, California +142 more

RECRUITING

Nectero EAST System Clinical Study

PHASE2, PHASE3 Scottsdale, Arizona +38 more

RECRUITING

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

PHASE1, PHASE2 Birmingham, Alabama +162 more

RECRUITING

Cardiac Sarcoidosis Randomized Trial

PHASE3 New Haven, Connecticut +30 more

RECRUITING

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

PHASE1 Lenexa, Kansas +1 more

RECRUITING

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

PHASE2 Daphne, Alabama +265 more

RECRUITING

Clinical Decision Support Tool in PARDS Pilot Study

NA Chicago, Illinois +7 more

RECRUITING

Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

PHASE2 Redwood City, California +1 more

RECRUITING

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

PHASE2 Palo Alto, California +3 more

RECRUITING

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

NA Birmingham, Alabama +31 more

RECRUITING